6-Acetamidohexanoic acid Chemical Properties

Melting point:

102-104 °C(lit.)

Boiling point:

303.86°C (rough estimate)

Density 

1.1599 (rough estimate)

refractive index 

1.4590 (estimate)

storage temp. 

Sealed in dry,Room Temperature

solubility 

DMSO (Sparingly), Methanol (Slightly)

pka

4.75±0.10(Predicted)

form 

Solid

color 

White to Off-White

Merck 

14,45

LogP

-0.500 (est)

CAS DataBase Reference

57-08-9(CAS DataBase Reference)

Safety Information

Safety Statements 

24/25

WGK Germany 

3

HS Code 

29241900

MSDS

• Language:English Provider:epsilon-Acetamidocaproic acid
• Language:English Provider:SigmaAldrich
• Language:English Provider:ACROS
• Language:English Provider:ALFA

6-Acetamidohexanoic acid Usage And Synthesis

Chemical Properties

WHITE POWDER

Originator

Acexamic acid ,Flamma

Uses

wound healing agent

Uses

6-Acetamidohexanoic acid is used after oral administration of an antiulcer agent, zinc acexamate (ZAC) for treatment of gastric ulcer or small bowel inflammation.

Definition

ChEBI: Acexamic acid is a medium-chain fatty acid.

Manufacturing Process

400 L of demineralized water, 5.0 kg of calcium hydroxide, and 155.0 kg (1000 moles) of acetyl-caprolactame are introduced under stirring and at a temperature of about 25°C into a 1000 L stainless double walled reactor.
The temperature is raised to 30°C. 75.0 kg of calcium hydroxide are introduced stepwise in the form of successive amounts of 2.0 kg each in the medium, under stirring and at a temperature adjusted and maintained 25°- 30°C through external cooling, in a manner such that the time required to introduce into the reactor the whole amount of calcium hydroxide approximates 1.5 h. When the stirring is stopped, the pH is about 7.5-7.8.
The obtained mixture is stirred continuously at a temperature of 30°C during 14 h. At the end of this operation the pH is again adjusted at a value 7.5-7.8.
The hydrolysate is filtered on a 60 x 60 pressfilter comprising 6 compartments and equipped with fabrics of the polyester known under the designation TERGAL which have been previously coated with a suspension of a cellulose commercialized under the trademark SOLKA FLOX BW20. The duration of filtration is of 1.5 h. 580 L of the filtrate are recovered and subjected to a concentration under reduced pressure in an evaporator the volume of which is of 750 L, at a distillation temperature ranging from 45°-50°C under a reduced pressure of 10-15 Torr.
The operation is ran until concentration of the solution to 280 L, the concentrated solution being then left standing. The crystallisation is already considerable 2 h after the end of the operation of concentration. Crystallisation is ended after 16-24 h.
The crystals are centrifuged at a speed of 700 revolutions/minute. The centrifuged crystals of calcium acexamate are washed twice on the centrifuge with 20 l of acetone. 107.0 kg of crystals are obtained, which are dried under vacuum at 40°C. The 96.0 kg of dry calcium acexamate obtained are ground and sifted.
Acexamic acid may be produced by treatment of the calcium acexamate with HCl.

Therapeutic Function

Antifibrinolytic

6-Acetamidohexanoic acid(57-08-9)Related Product Information

• 6-Aminocaproic acid
• Acetaminophen
• Hexanoic acid
• Ethyl Hexanoate
• Hydroxyprogesterone caproate
• Hexyl hexanoate
• Allyl hexanoate
• Acetylsalicylic acid
• Methyl hexanoate
• Acetylspiramycin
• Ethyl 2-(Chlorosulfonyl)acetate
• Acetylcholine
• ZINC ACEXAMATE
• N-EPSILON-BENZOYL-L-LYSINE
• N-EPSILON-ACETYL-L-LYSINE
• 6-Maleimidocaproic acid
• SMCC crosslinker
• N-6-Trifluoroacetyl-L-lysine